No title
Background: Uterine sarcomas are rare and high-quality evidence regarding optimal treatment is limited and difficult to produce. Methods: A total of 618 patients with uterine sarcoma were identified in the Swedish Quality Registry for Gynecologic Cancer (SQRGC) from 2010 to 2020. Survival was analyzed according to stage, histology and treatment modality. Results: The incidence of uterine sarcoma w
